Coagulopathy: Another Side Effect of Coronavirus Infection Publisher



Sadoughi F¹ ; Dana PM¹ ; Hallajzadeh J² ; Asemi Z¹ ; Mansournia MA³ ; Yousefi B⁴
Source: Journal of Cardiovascular and Thoracic Research Published:2021

Abstract

Recently, coronavirus disease 2019 (COVID-19) has been considered as a major health problem around the globe. This severe acute respiratory syndrome has a bunch of features, such as high transmission rate, which are adding to its importance. Overcoming this disease relies on a complete understanding of the viral structure, receptors, at-risk cells or tissues, and pathogenesis. Currently, researches have shown that besides the lack of a proper anti-viral therapeutic method, complications provided by this virus are also standing in the way of decreasing its mortality rate. One of these complications is believed to be a hematologic manifestation. Commonly, three kinds of coagulopathies are detected in COVID-19 patients: disseminated intravascular coagulation (DIC), pulmonary embolism (PE), and deep vein thrombosis (DVT). In this paper, we have reviewed the relation between these conditions and coronavirus-related diseases pathogenesis, severity, and mortality rate. © 2021 The Author(s).